Prof Eoin O’Brien, Professor of Molecular Pharmacology at the Conway Institute, UCD, examines the rationale for increased use of single-pill combinations, which he believes can contribute significantly to achieving BP control in a cost-effective manner.
Researchers at the NUI Galway have identified an enzyme that has a key role in the spread and survival of blood cancer cells. The discovery, which focused on the cancer multiple myeloma, has just been published in the international journal, Blood.
A new study conducted by researchers from the RCSI shows that higher selenium levels are associated with decreased risk of bowel cancer, especially in women.
Eight out of 10 patients undergoing interventions for aortic stenosis are in the same or better health one year after procedure, new research has found.
Vision loss is associated with a higher likelihood of not working, researchers from Johns Hopkins Hospital, Baltimore, have found.
Despite the introduction of endovenous surgery, the majority of patients are still managed by open varicose veins surgery and recurrent varicose veins may not be suitable for endovenous surgery, Gary Culliton reports in his latest Clinical Update.
Psychiatrists are only beginning to understand the complex bio-psycho-social challenges of psychosis, writes Dr Stephen McWilliams, the consultant lead of the Psychosis Programme at Saint John of God Hospital.
The vast majority of dialysis patients are on standard (CHD) three-times-per-week treatment, Gary Culliton reports in his latest Clinical Update. Treatments usually last four hours at a time. There is good clinical data suggesting benefit if the dialysis is done more frequently, also known as High Dose HD.
There are an estimated 1.9 million end-stage renal disease (ESRD) patients receiving renal replacement therapy worldwide, with the vast majority receiving conventional haemodialysis (CHD), which is usually performed three times a week for three to five hours per session in a centre or clinic.